ASX - By Stock
|
PWN |
Re:
Broker Breifing Presentation
|
|
supertramp
|
5 |
1.9K |
5 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
5
|
1.9K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
supertramp
|
1.5K |
649K |
8 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
1.5K
|
649K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Best value stock on asx
|
|
supertramp
|
14 |
8.2K |
30 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
14
|
8.2K
|
30
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Parkway Corporate Presentation
|
|
supertramp
|
29 |
12K |
14 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
29
|
12K
|
14
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Parkway Corporate Presentation
|
|
supertramp
|
29 |
12K |
14 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
29
|
12K
|
14
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Annual Report to Shareholders
|
|
supertramp
|
17 |
5.9K |
2 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
17
|
5.9K
|
2
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Annual Report to Shareholders
|
|
supertramp
|
17 |
5.9K |
12 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
17
|
5.9K
|
12
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
supertramp
|
3.2K |
1.0M |
2 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Extension of Share Purchase Plan
|
|
supertramp
|
68 |
23K |
19 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
68
|
23K
|
19
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Extension of Share Purchase Plan
|
|
supertramp
|
68 |
23K |
7 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
68
|
23K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Extension of Share Purchase Plan
|
|
supertramp
|
68 |
23K |
8 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
68
|
23K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Preclinical trial of ALA iNKT therapy and IMU onCARlytics
|
|
supertramp
|
75 |
42K |
8 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
75
|
42K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Preclinical trial of ALA iNKT therapy and IMU onCARlytics
|
|
supertramp
|
75 |
42K |
7 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
75
|
42K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX unveils CellPryme-A to boost CAR-T performance
|
|
supertramp
|
51 |
20K |
23 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
51
|
20K
|
23
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
19 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
181
|
65K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
supertramp
|
255 |
158K |
10 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
255
|
158K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
supertramp
|
3.2K |
1.2M |
12 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
3.2K
|
1.2M
|
12
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX strategic collaboration with MD Anderson Cancer Center
|
|
supertramp
|
47 |
19K |
39 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
47
|
19K
|
39
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
24 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
181
|
65K
|
24
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
13 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
181
|
65K
|
13
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
18 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
181
|
65K
|
18
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
9 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
181
|
65K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
25 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
181
|
65K
|
25
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
9 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
181
|
65K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
10 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
181
|
65K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
9 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
181
|
65K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Therapeutics Launches Share Purchase Plan
|
|
supertramp
|
181 |
65K |
24 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
181
|
65K
|
24
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
supertramp
|
3.2K |
1.2M |
14 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
3.2K
|
1.2M
|
14
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
supertramp
|
3.2K |
1.2M |
28 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
3.2K
|
1.2M
|
28
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX Presentation
|
|
supertramp
|
28 |
9.3K |
28 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
28
|
9.3K
|
28
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX agreement with Thermo Fisher for scalable OmniCAR
|
|
supertramp
|
131 |
46K |
27 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
131
|
46K
|
27
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX agreement with Thermo Fisher for scalable OmniCAR
|
|
supertramp
|
131 |
46K |
19 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
131
|
46K
|
19
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX agreement with Thermo Fisher for scalable OmniCAR
|
|
supertramp
|
131 |
46K |
20 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
131
|
46K
|
20
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
supertramp
|
1.5K |
649K |
18 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
1.5K
|
649K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supertramp
|
25K |
12M |
46 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
25K
|
12M
|
46
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supertramp
|
25K |
12M |
78 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
25K
|
12M
|
78
|
|
ASX - By Stock
|
PWN |
Re:
Catch Up with Bahay Jun Qtr 22
|
|
supertramp
|
65 |
22K |
17 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
65
|
22K
|
17
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
supertramp
|
24 |
7.4K |
7 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
24
|
7.4K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
supertramp
|
3.2K |
1.2M |
7 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
3.2K
|
1.2M
|
7
|
|
ASX - By Stock
|
PWN |
Re:
general chat/ thoughts
|
|
supertramp
|
3.2K |
1.0M |
8 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
|
|
supertramp
|
63 |
24K |
28 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
63
|
24K
|
28
|
|
ASX - By Stock
|
PTX |
Re:
Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
|
|
supertramp
|
63 |
24K |
25 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
63
|
24K
|
25
|
|
ASX - By Stock
|
PTX |
Re:
Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
|
|
supertramp
|
63 |
24K |
11 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
63
|
24K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
|
|
supertramp
|
63 |
24K |
34 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
63
|
24K
|
34
|
|
ASX - By Stock
|
PTX |
Re:
Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
|
|
supertramp
|
63 |
24K |
38 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
63
|
24K
|
38
|
|
ASX - By Stock
|
PTX |
Re:
Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
|
|
supertramp
|
63 |
24K |
21 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
63
|
24K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Hmm interesting... Very very interesting... Time to buy?
|
|
supertramp
|
435 |
246K |
45 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
435
|
246K
|
45
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
supertramp
|
1.5K |
649K |
32 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
1.5K
|
649K
|
32
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX unveils new clinic-ready CAR-T enhancement platform
|
|
supertramp
|
101 |
44K |
26 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
101
|
44K
|
26
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX unveils new clinic-ready CAR-T enhancement platform
|
|
supertramp
|
101 |
44K |
23 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
101
|
44K
|
23
|
|